Home Diagnostics, Inc. 

(Public, NASDAQ:HDIX)   Watch this stock   
Find more results for HDIX
Nov 5, 2009
Q3 2009 HOME DIAGNOSTICS INC DEL Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin 5.81% 7.80%
Operating margin 8.48% 9.03%
EBITD margin - 12.59%
Return on average assets 5.48% 7.10%
Return on average equity 7.03% 8.84%
Employees 571 -

Address

2400 NW 55th Court
Fort Lauderdale, FL 33309
United States - Map
+1-954-6779201 (Phone)
+1-954-7398506 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Home Diagnostics, Inc. discussed on blogs

Diabetes Care: Global Investing Opportunities - BioMedReports.com - Mike Havrilla - BioMedReports.Com - 23 hours ago
Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Home Diagnostics, Inc. discussions

  View all discussions »

Description

Home Diagnostics, Inc. (HDI), develops, manufactures and markets of blood glucose monitoring systems and disposable supplies for people with diabetes worldwide. HDI partners with food and drug retailers, mass merchandisers, distributors, mail service providers and third-party payors in the United States and internationally to deliver its products to people with diabetes. The Company markets its products under its own brands, including TRUEresult, TRUE2go, TRUEtest, TRUEtrack, Sidekick, TRUEread and Prestige IQ, and under a co-branded format through which HDI adds its customers’ store brand name to its brand name products. HDI also markets its products to managed care organizations including health plans and pharmacy benefits managers (PBMs) for inclusion on formularies, which are lists of approved products from which the insured or member and their physicians can choose, and granting of preferred product status by health plans.

Officers and directors

George H. Holley
Chairman of the Board
Age: 68
Bio & Compensation - Reuters
Joseph H. Capper
President, Chief Executive Officer, Director
Age: 45
Bio & Compensation - Reuters
Donald P. Parson
Vice Chairman of the Board
Age: 67
Bio & Compensation - Reuters
Ronald L. Rubin
Chief Financial Officer, Senior Vice President, Secretary
Age: 43
Bio & Compensation - Reuters
Scott I. Verner
Senior Vice President - Sales and Marketing
Age: 44
Bio & Compensation - Reuters
George S. Godfrey
Vice President - Operations
Age: 43
Bio & Compensation - Reuters
Gregg A. Johnson
Vice President - Consumer Healthcare
Age: 48
Bio & Compensation - Reuters
T. Gary Neel
Vice President - Research & Development
Age: 46
Bio & Compensation - Reuters
Christopher J. Avery
Managing Director of Home Diagnostics (UK) Limited
Age: 46
Bio & Compensation - Reuters
Robert Tsao
Managing Director of Applied Sciences Corporation
Age: 52
Bio & Compensation - Reuters